Traditional remedies and the “test of time” E. ErnstP. A. G. M. De SmetV. Murray DEBATE ARTICLE Pages: 99 - 100
Use and abuse of placebo in phase III trials F. García-AlonsoE. GuallarX. Carné Cladellas Special review Pages: 101 - 105
Single-dose dextropropoxyphene in post-operative pain: a quantitative systematic review S. L. CollinsJ. E. EdwardsH. J. McQuay CLINICAL TRIALS Pages: 107 - 112
Drug utilization 90% – a simple method for assessing the quality of drug prescribing U. BergmanC. PopaF. Sjöqvist PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 113 - 118
Drug use in Estonia in 1994–1995: a follow-up from 1989 and comparison with two Nordic countries R. A. KiivetU. BergmanF. Sjöqvist PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 119 - 124
Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study L. F. Van GaalJ. I. BroomThe Orlistat Dose-Ranging Study Group PHARMACODYNAMICS Pages: 125 - 132
Desmin (a low molecular weight dermatan sulphate) versus heparin in the treatment of patients with deep venous thrombosis K. von KempK. JochmansP. Van den Brande PHARMACODYNAMICS Pages: 133 - 139
The extrapulmonary effects of increasing doses of formoterol in patients with asthma C. D. BurgessM. AysonM. D. Till PHARMACODYNAMICS Pages: 141 - 147
Interaction between timolol eyedrops and oral nicardipine or oral diltiazem in healthy Japanese subjects Y. I. YatsukaK. TsutsumiK. Nakatsuka PHARMACODYNAMICS Pages: 149 - 154
Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients S. JaruratanasirikulS. Sriwiriyajan PHARMACOKINETICS AND DISPOSITION Pages: 155 - 158
Effect of omeprazole on the pharmacokinetics of itraconazole S. JaruratanasirikulS. Sriwiriyajan PHARMACOKINETICS AND DISPOSITION Pages: 159 - 161
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem H. LuurilaK. T. KivistöP. J. Neuvonen PHARMACOKINETICS AND DISPOSITION Pages: 163 - 166
Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole K. RaaskaP. J. Neuvonen PHARMACOKINETICS AND DISPOSITION Pages: 167 - 170
Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients C. SabotP. MarquetG. Lachâtre PHARMACOKINETICS AND DISPOSITION Pages: 171 - 175
Prediction of drug-drug interactions of zonisamide metabolism in humans from in vitro data H. NakasaH. NakamuraM. Kitada PHARMACOKINETICS AND DISPOSITION Pages: 177 - 183
Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates Albert P. AldenkampT. RentmeesterM. Olling PHARMACOKINETICS AND DISPOSITION Pages: 185 - 192
Drug-induced systemic lupus erythematosus after 8 years of treatment with carbamazepine M. ToepferT. SitterW. Müller-Felber Case Report Pages: 193 - 194